Surgery for Gastric Remnant Cancer Results in Similar Overall Survival Rates Compared with Primary Gastric Cancer: A Propensity Score-Matched Analysis.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
27
11
2019
pubmed:
4
6
2020
medline:
6
5
2021
entrez:
4
6
2020
Statut:
ppublish
Résumé
The purpose of this study was to investigate clinical features, prognostic factors, and overall survival (OS) in surgical patients with gastric remnant cancer (GRC). A retrospective analysis of patients with gastrectomy for pT1-4 gastric cancer between October 1972 and February 2014 at our institution was performed. Clinical characteristics were compared between patients with GRC and those with primary gastric cancer (PGC). Multivariable Cox regression analysis was performed to determine the prognostic factors for OS in patients with GRC. A propensity score-matched cohort was used to investigate OS between the GRC and PGC groups. Of a baseline cohort of 1440 patients, 95 patients with GRC were identified. Patients with GRC underwent more multivisceral resections (p < 0.001) than patients with PGC despite lower tumor stages (p = 0.018); however, R0 resection rates were not significantly different (p = 0.211). The postoperative overall (p = 0.032) and major surgical (p = 0.021) complication rates and the 30-day (p = 0.003) and in-hospital (p = 0.008) mortality rates were higher in patients with GRC. In multivariable analysis, the only prognostic factors for worse OS in GRC were higher tumor stage (p < 0.001) and the occurrence of postoperative complications (p < 0.001). OS between propensity score-matched GRC and PGC groups was not significantly different (p = 0.772). GRC required more invasive surgery than PGC; however, the feasibility of R0 resection was similar. The prognostic factors of GRC were similar to those of PGC, and OS was not significantly different between both groups. Patients with GRC benefit from extensive surgery when performed with low morbidity and mortality.
Sections du résumé
BACKGROUND
BACKGROUND
The purpose of this study was to investigate clinical features, prognostic factors, and overall survival (OS) in surgical patients with gastric remnant cancer (GRC).
METHODS
METHODS
A retrospective analysis of patients with gastrectomy for pT1-4 gastric cancer between October 1972 and February 2014 at our institution was performed. Clinical characteristics were compared between patients with GRC and those with primary gastric cancer (PGC). Multivariable Cox regression analysis was performed to determine the prognostic factors for OS in patients with GRC. A propensity score-matched cohort was used to investigate OS between the GRC and PGC groups.
RESULTS
RESULTS
Of a baseline cohort of 1440 patients, 95 patients with GRC were identified. Patients with GRC underwent more multivisceral resections (p < 0.001) than patients with PGC despite lower tumor stages (p = 0.018); however, R0 resection rates were not significantly different (p = 0.211). The postoperative overall (p = 0.032) and major surgical (p = 0.021) complication rates and the 30-day (p = 0.003) and in-hospital (p = 0.008) mortality rates were higher in patients with GRC. In multivariable analysis, the only prognostic factors for worse OS in GRC were higher tumor stage (p < 0.001) and the occurrence of postoperative complications (p < 0.001). OS between propensity score-matched GRC and PGC groups was not significantly different (p = 0.772).
CONCLUSIONS
CONCLUSIONS
GRC required more invasive surgery than PGC; however, the feasibility of R0 resection was similar. The prognostic factors of GRC were similar to those of PGC, and OS was not significantly different between both groups. Patients with GRC benefit from extensive surgery when performed with low morbidity and mortality.
Identifiants
pubmed: 32488518
doi: 10.1245/s10434-020-08669-2
pii: 10.1245/s10434-020-08669-2
pmc: PMC8502152
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4196-4203Commentaires et corrections
Type : ErratumIn
Références
World J Surg. 1986 Jun;10(3):454-61
pubmed: 3727608
Arch Surg. 1987 Mar;122(3):300-3
pubmed: 3827568
Hepatogastroenterology. 2003 Mar-Apr;50(50):587-91
pubmed: 12749279
J Surg Oncol. 2015 Feb;111(2):208-12
pubmed: 25175816
Int Surg. 1987 Oct-Dec;72(4):222-6
pubmed: 3448034
Int J Cancer. 2012 Sep 15;131(6):E1048-52
pubmed: 22532306
Hepatogastroenterology. 2004 Jan-Feb;51(55):82-5
pubmed: 15011835
Am J Surg. 2007 Jul;194(1):63-7
pubmed: 17560911
World J Surg Oncol. 2019 Mar 18;17(1):52
pubmed: 30885211
Ann Surg. 2000 Feb;231(2):188-94
pubmed: 10674609
Gastric Cancer. 2002;5(1):16-22
pubmed: 12021855
World J Surg. 2010 Jul;34(7):1540-7
pubmed: 20182716
Eur J Surg Oncol. 2016 Jan;42(1):132-9
pubmed: 26385054
Ann Surg Oncol. 2018 Sep;25(9):2693-2702
pubmed: 29987609
Eur J Surg Oncol. 2007 Mar;33(2):133-9
pubmed: 17071041
Gastric Cancer. 2012 Jan;15(1):42-8
pubmed: 21573917
Acta Chir Scand. 1986 Mar;152:199-204
pubmed: 3716739
Cancer. 1994 Jan 1;73(1):15-21
pubmed: 8275417
Ann Surg Oncol. 2019 Oct;26(11):3618-3626
pubmed: 31222685
J Clin Gastroenterol. 1996 Dec;23(4):251-5
pubmed: 8957725
Br J Surg. 1991 Jul;78(7):822-4
pubmed: 1873711
Ann Surg. 1922 Sep;76(3):405-8
pubmed: 17864703
Am J Surg. 1997 Apr;173(4):292-7
pubmed: 9136783
Br J Surg. 2005 Feb;92(2):235-9
pubmed: 15609385